GO:1901705 L-isoleucine biosynthetic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901705 defines the chemical reactions and pathways that result in the formation of L-isoleucine, an essential branched-chain amino acid.
• The pathway is best characterized in bacteria such as Corynebacterium glutamicum and Escherichia coli, where it is a major target for industrial amino acid production [1, 8].
• Key enzymes include threonine dehydratase (IlvA), acetohydroxyacid synthase (IlvBN/IlvIH), ketol-acid reductoisomerase (IlvC), dihydroxyacid dehydratase (IlvD), and branched-chain aminotransferase (IlvE) [1, 8].
• L-isoleucine biosynthesis is tightly regulated by feedback inhibition and transcriptional attenuation in response to intracellular L-isoleucine levels.
• Dysregulation of branched-chain amino acid metabolism, including L-isoleucine, is linked to metabolic disorders and cancer [3, 8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of L-isoleucine biosynthetic genes in diverse organisms [2, 8].
Description
L-isoleucine is an essential branched-chain amino acid that serves as a building block for proteins and as a precursor for various secondary metabolites. The Gene Ontology term GO:1901705, L-isoleucine biosynthetic process, describes the set of chemical reactions and pathways that lead to the formation of L-isoleucine from simpler precursors. This process is of fundamental importance in microbiology, metabolic engineering, and human health because L-isoleucine cannot be synthesized by humans and must be obtained from the diet or from gut microbiota [1, 8]. In bacteria such as Corynebacterium glutamicum and Escherichia coli, the L-isoleucine biosynthetic pathway has been extensively studied and engineered for industrial production of this amino acid [1, 8]. The pathway also intersects with the biosynthesis of L-valine and L-leucine, sharing several enzymes and regulatory mechanisms [1, 3]. Understanding GO:1901705 is therefore critical for researchers aiming to manipulate amino acid production, study metabolic regulation, and develop therapeutic strategies for diseases linked to branched-chain amino acid metabolism [3, 8].
L-isoleucine biosynthetic process At A Glance
| GO ID | GO:1901705 |
|---|---|
| GO term | L-isoleucine biosynthetic process |
| Ontology | biological_process |
| Synonym | L-isoleucine anabolism, L-isoleucine biosynthesis, L-isoleucine formation, L-isoleucine synthesis |
| Major function | Formation of L-isoleucine from metabolic precursors |
| Key enzymes | Threonine dehydratase, acetohydroxyacid synthase, ketol-acid reductoisomerase, dihydroxyacid dehydratase, branched-chain aminotransferase |
| Organisms | Bacteria (e.g., Corynebacterium glutamicum, Escherichia coli), plants, fungi |
| Regulation | Feedback inhibition by L-isoleucine, transcriptional attenuation |
| Related pathways | L-valine biosynthesis, L-leucine biosynthesis, branched-chain amino acid metabolism |
What Is GO:1901705?
GO:1901705, L-isoleucine biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of L-isoleucine. This biological process encompasses the enzymatic steps that convert precursors such as L-threonine and pyruvate into L-isoleucine, typically through a series of reactions including deamination, condensation, reduction, dehydration, and transamination [1, 8]. The term is used in gene ontology annotations to describe the function of gene products involved in this specific metabolic route.
Why Is L-isoleucine biosynthetic process Important in Cell Biology?
The L-isoleucine biosynthetic process is a central metabolic pathway that not only provides an essential amino acid for protein synthesis but also serves as a model system for understanding enzyme kinetics, metabolic regulation, and pathway engineering [1, 8]. In industrial biotechnology, optimizing this pathway in Corynebacterium glutamicum and Escherichia coli has led to high-yield production of L-isoleucine for food, feed, and pharmaceutical applications [1, 8]. In medicine, altered L-isoleucine metabolism is associated with metabolic disorders such as maple syrup urine disease and with cancer cell proliferation, making the pathway a potential therapeutic target [3, 8]. Furthermore, the pathway is interconnected with mitochondrial metabolism and isobutanol production in engineered yeast, highlighting its broader biotechnological relevance.
• Provides L-isoleucine, an essential amino acid required for protein synthesis in humans and animals.
• Serves as a key target for metabolic engineering to produce L-isoleucine industrially [1, 8].
• Shares enzymes and regulatory mechanisms with L-valine and L-leucine biosynthesis, affecting overall branched-chain amino acid balance [1, 3].
• Dysregulation is linked to metabolic disorders such as maple syrup urine disease.
• Altered L-isoleucine metabolism is observed in cancer cells, where it supports proliferation.
• Enables the production of value-added compounds such as isobutanol when combined with other pathways.
• Provides a model for studying feedback inhibition and transcriptional attenuation in amino acid biosynthesis.
• Facilitates the development of microbial cell factories for sustainable production of chemicals [2, 8].
• Contributes to the understanding of mitochondrial amino acid metabolism in eukaryotes.
• Supports research on co-production of L-isoleucine with other metabolites like S-adenosyl-L-methionine.
What Happens During L-isoleucine biosynthetic process?
Conversion of L-threonine to 2-ketobutyrate
In simple terms: The pathway starts by removing an ammonia group from L-threonine to make a reactive intermediate.
The first committed step in L-isoleucine biosynthesis is the deamination of L-threonine to 2-ketobutyrate, catalyzed by threonine dehydratase (IlvA). This enzyme requires pyridoxal phosphate as a cofactor and is subject to feedback inhibition by L-isoleucine. In Corynebacterium glutamicum, the ilvA gene encodes this enzyme, and its activity is critical for flux into the pathway.
Condensation to form acetohydroxy acids
In simple terms: The intermediate from the first step combines with pyruvate to build a larger molecule.
2-Ketobutyrate condenses with pyruvate to form 2-aceto-2-hydroxybutyrate, a reaction catalyzed by acetohydroxyacid synthase (AHAS, encoded by ilvBN in C. glutamicum or ilvIH in E. coli) [1, 8]. This enzyme also participates in L-valine biosynthesis, making it a branch point for regulation. AHAS requires thiamine diphosphate and divalent cations for activity.
Reduction and dehydration to 2-keto-3-methylvalerate
In simple terms: The molecule is chemically modified through reduction and water removal to form a keto acid.
2-Aceto-2-hydroxybutyrate is reduced to 2,3-dihydroxy-3-methylvalerate by ketol-acid reductoisomerase (IlvC), which uses NADPH. This intermediate is then dehydrated by dihydroxyacid dehydratase (IlvD) to yield 2-keto-3-methylvalerate. These steps are shared with L-valine biosynthesis and are essential for pathway progression.
Transamination to L-isoleucine
In simple terms: The final step adds an amino group to the keto acid to produce L-isoleucine.
The final step is a transamination of 2-keto-3-methylvalerate to L-isoleucine, catalyzed by branched-chain aminotransferase (IlvE) using L-glutamate as the amino donor [1, 8]. In E. coli, IlvE is also involved in L-valine and L-leucine synthesis. This reaction completes the biosynthetic pathway defined by GO:1901705.
Regulation of pathway flux
In simple terms: The cell controls how much L-isoleucine is made by sensing its levels and adjusting enzyme activity.
L-isoleucine biosynthesis is regulated at multiple levels. Threonine dehydratase (IlvA) is feedback-inhibited by L-isoleucine, and in some bacteria, transcriptional attenuation controls the expression of the ilv operon in response to charged tRNA-Ile levels. In C. glutamicum, engineering strategies often relieve this regulation to increase production. Additionally, the pathway is influenced by the availability of precursors such as pyruvate and L-threonine.
Key Genes Involved in GO:1901705 L-isoleucine biosynthetic process
The following genes and enzymes are central to the L-isoleucine biosynthetic process across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ilvA | Threonine dehydratase, converts L-threonine to 2-ketobutyrate | First committed step; feedback inhibited by L-isoleucine |
| ilvBN | Acetohydroxyacid synthase, condenses 2-ketobutyrate and pyruvate | Branch point with L-valine biosynthesis; target for engineering |
| ilvC | Ketol-acid reductoisomerase, reduces acetohydroxy acid | Shared with L-valine pathway; NADPH-dependent |
| ilvD | Dihydroxyacid dehydratase, dehydrates dihydroxy acid | Essential for pathway flux; potential knockout target |
| ilvE | Branched-chain aminotransferase, transaminates keto acid | Final step; also involved in L-valine and L-leucine synthesis |
| ilvIH | Acetohydroxyacid synthase isozyme in E. coli | Alternative AHAS for pathway engineering |
| ilvG | Acetohydroxyacid synthase II in E. coli | Contributes to L-isoleucine and L-valine synthesis |
| ilvM | Small subunit of AHAS II in E. coli | Regulatory subunit; affects enzyme activity |
| thrA | Aspartokinase-homoserine dehydrogenase, produces L-threonine | Upstream precursor supply for L-isoleucine |
| thrB | Homoserine kinase, converts homoserine to O-phosphohomoserine | Precursor for L-threonine and L-isoleucine |
| thrC | Threonine synthase, forms L-threonine | Direct precursor for L-isoleucine |
| leuA | 2-Isopropylmalate synthase, involved in L-leucine synthesis | Shares precursors with L-isoleucine pathway |
| leuB | 3-Isopropylmalate dehydrogenase | L-leucine biosynthesis; affects branched-chain amino acid balance |
| leuC | Isopropylmalate isomerase large subunit | L-leucine pathway; potential cross-regulation |
| leuD | Isopropylmalate isomerase small subunit | L-leucine pathway; model for pathway interplay |
| batA | Branched-chain aminotransferase in some bacteria | Alternative transaminase for L-isoleucine synthesis |
| ido | L-isoleucine dioxygenase, degrades L-isoleucine | Catabolic enzyme; not biosynthetic but relevant to flux |
| sahH | S-adenosylhomocysteine hydrolase, affects methyl cycle | Co-production studies with L-isoleucine |
How Is L-isoleucine biosynthetic process Regulated?
L-isoleucine biosynthesis is regulated primarily through feedback inhibition of threonine dehydratase (IlvA) by L-isoleucine and through transcriptional attenuation of the ilv operon in response to intracellular L-isoleucine levels. In Corynebacterium glutamicum, the ilvA gene is subject to feedback inhibition, and mutations that relieve this inhibition are commonly used to enhance production. Additionally, global regulators such as the stringent response and carbon source availability can influence pathway expression. In engineered E. coli, self-induced production systems have been developed to decouple growth from L-isoleucine synthesis, highlighting the importance of dynamic regulation.
L-isoleucine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCKDHA | Maple syrup urine disease | Knockout in HepG2 cells to model metabolic block |
| ILV pathway genes | Cancer cell proliferation | Knockout in cancer cell lines to test dependency |
| ILV2/ILV3 (yeast) | Mitochondrial isobutanol production | Knockout in S. cerevisiae to redirect flux |
| ilvA | Bacterial metabolic engineering | Point mutation to relieve feedback inhibition |
| ilvBN | Industrial L-isoleucine production | Overexpression in C. glutamicum |
Maple Syrup Urine Disease and Branched-Chain Amino Acid Metabolism
Maple syrup urine disease (MSUD) is an inherited metabolic disorder caused by defects in the branched-chain alpha-ketoacid dehydrogenase complex, leading to accumulation of L-isoleucine, L-leucine, and L-valine. Although the biosynthetic pathway itself is not directly mutated in MSUD, understanding L-isoleucine biosynthesis is essential for modeling the metabolic imbalance and developing therapeutic strategies.
Cancer Metabolism and L-Isoleucine Dependency
Certain cancer cells exhibit increased demand for branched-chain amino acids, including L-isoleucine, to support rapid proliferation. Metabolic engineering studies in E. coli have provided insights into L-isoleucine production and regulation, which can be translated to understand cancer cell metabolism. Targeting L-isoleucine biosynthetic enzymes in tumors that rely on de novo synthesis is an emerging area of research.
Mitochondrial Metabolism and Isobutanol Production
In Saccharomyces cerevisiae, elimination of mitochondrial L-valine and L-isoleucine biosynthetic pathways enhances isobutanol production, linking the pathway to mitochondrial amino acid metabolism. This has implications for understanding mitochondrial dysfunction and for engineering yeast for biofuel production.
From L-isoleucine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of ilvA abolish L-isoleucine biosynthesis? | CRISPR knockout in C. glutamicum or E. coli [1, 8] |
| Can a point mutation in ilvA relieve feedback inhibition? | CRISPR point mutation in C. glutamicum |
| Does knock-in of a heterologous ilv operon enhance production? | CRISPR knock-in in E. coli |
| Does overexpression of ilvBN increase flux? | CRISPR overexpression in C. glutamicum |
| What is the effect of ilvD deletion on isobutanol production? | CRISPR knockout in S. cerevisiae |
| Can self-induced production be achieved? | CRISPR-mediated promoter replacement in E. coli |
How to Study the L-isoleucine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C Metabolic Flux Analysis | Carbon flux through pathway | Quantify L-isoleucine production in engineered strains |
| Enzyme activity assay | Catalytic activity and inhibition | Characterize IlvA mutants |
| RNA-seq | Gene expression changes | Identify regulatory responses in knockout strains |
| Proteomics | Protein abundance | Validate overexpression or knockout effects |
| CRISPR screening | Gene essentiality and fitness | Identify host dependency factors |
| HPLC | L-isoleucine concentration | Measure production titers [1, 8] |
| GC-MS | Metabolite profiling | Detect pathway intermediates |
| Western blot | Protein levels | Confirm knock-in or overexpression |
Metabolic Flux Analysis
Metabolic flux analysis using 13C-labeled substrates allows quantification of carbon flow through the L-isoleucine biosynthetic pathway. This method is essential for identifying bottlenecks and evaluating engineering strategies in production strains.
Enzyme Activity Assays
In vitro enzyme assays for threonine dehydratase, acetohydroxyacid synthase, and other pathway enzymes provide direct measurements of catalytic activity and feedback inhibition. These assays are used to characterize mutant enzymes generated by CRISPR.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal expression changes in ilv genes under different conditions or in knockout strains. These approaches help identify regulatory networks and compensatory mechanisms.
CRISPR Screening
Genome-wide CRISPR libraries can be used to identify genes that affect L-isoleucine biosynthesis or dependency in mammalian cells. This is particularly useful for uncovering host factors in cancer metabolism.
How CRISPR Can Be Used to Study GO:1901705 L-isoleucine biosynthetic process
Knockout
CRISPR knockout of ilvA, ilvBN, ilvC, ilvD, or ilvE can abolish L-isoleucine biosynthesis, confirming their essential roles [1, 8]. In C. glutamicum, knockout of ilvA results in L-isoleucine auxotrophy, which can be complemented by exogenous L-isoleucine. In S. cerevisiae, knockout of mitochondrial ilv genes redirects flux to isobutanol.
Point Mutation
CRISPR point mutation can be used to introduce specific amino acid substitutions in ilvA to relieve feedback inhibition by L-isoleucine. Such mutations are valuable for increasing production titers in industrial strains. Point mutations in ilvBN can also alter substrate specificity or catalytic efficiency.
Knock-in
CRISPR knock-in allows integration of heterologous ilv operons or promoter replacements to enhance pathway expression. In E. coli, knock-in of a self-induced production system enables dynamic control of L-isoleucine synthesis. Knock-in of ilv genes into C. glutamicum can improve production yields.
Overexpression
CRISPR activation (CRISPRa) or plasmid-based overexpression can increase the expression of ilv genes to boost flux through the pathway [1, 8]. Overexpression of ilvBN and ilvC in C. glutamicum has been shown to enhance L-isoleucine production. In E. coli, overexpression of thrABC and ilvBN improves precursor supply and pathway flux.
How EDITGENE Supports L-isoleucine biosynthetic process Research
Researchers studying L-isoleucine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, production, or disease. EDITGENE provides comprehensive CRISPR services to enable precise genetic modifications in a wide range of cell models.
Contact EDITGENE today to design your custom CRISPR model for L-isoleucine biosynthetic process research.
Frequently Asked Questions About L-isoleucine biosynthetic process
What is L-isoleucine biosynthetic process?
It is the biological process defined by GO:1901705 that results in the formation of L-isoleucine from precursors such as L-threonine and pyruvate.
What genes are involved in L-isoleucine biosynthetic process?
Key genes include ilvA, ilvBN, ilvC, ilvD, and ilvE, which encode the enzymes catalyzing the pathway steps [1, 8].
Which organisms perform L-isoleucine biosynthesis?
Bacteria such as Corynebacterium glutamicum and Escherichia coli, as well as plants and fungi, perform this pathway [1, 8].
How is L-isoleucine biosynthesis regulated?
It is regulated by feedback inhibition of threonine dehydratase by L-isoleucine and by transcriptional attenuation of the ilv operon.
What is the first step in L-isoleucine biosynthesis?
The first committed step is the deamination of L-threonine to 2-ketobutyrate by threonine dehydratase (IlvA).
Can CRISPR be used to study L-isoleucine biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools to dissect the pathway and engineer production strains [1, 8].
What diseases are linked to L-isoleucine metabolism?
Maple syrup urine disease and certain cancers are associated with altered branched-chain amino acid metabolism, including L-isoleucine [3, 8].
How is L-isoleucine produced industrially?
Industrial production often uses engineered Corynebacterium glutamicum or Escherichia coli strains with optimized ilv genes and relieved feedback inhibition [1, 8].
What is the role of IlvE in L-isoleucine biosynthesis?
IlvE catalyzes the final transamination step to form L-isoleucine from 2-keto-3-methylvalerate [1, 8].
What methods are used to measure L-isoleucine production?
HPLC, GC-MS, and metabolic flux analysis are commonly used to quantify L-isoleucine and pathway intermediates [1, 3, 8].
Conclusion
The L-isoleucine biosynthetic process (GO:1901705) is a fundamental metabolic pathway with broad implications in microbiology, biotechnology, and human health. Understanding its enzymes, regulation, and interplay with other branched-chain amino acid pathways provides a foundation for metabolic engineering and therapeutic development [1, 8]. CRISPR-based tools offer unprecedented precision to study and manipulate this pathway, enabling advances in industrial production and disease research [1, 8].
References
- 1. Wang X. 2019. Strategy for improving L-isoleucine production efficiency in Corynebacterium glutamicum.. Appl Microbiol Biotechnol 103(5):2101-2111 PMID: 30663007
- 2. Wang L et al.. 2024. Heterotrophic and autotrophic production of L-isoleucine and L-valine by engineered Cupriavidus necator H16.. Bioresour Technol 398:130538 PMID: 38452952
- 3. Lee KM et al.. 2018. Elimination of biosynthetic pathways for l-valine and l-isoleucine in mitochondria enhances isobutanol production in engineered Saccharomyces cerevisiae.. Bioresour Technol 268:271-277 PMID: 30081287
- 4. Han G et al.. 2015. Co-production of S-adenosyl-L-methionine and L-isoleucine in Corynebacterium glutamicum.. Enzyme Microb Technol 78:27-33 PMID: 26215341
- 5. Smirnov SV et al.. 2013. A novel l-isoleucine-4'-dioxygenase and l-isoleucine dihydroxylation cascade in Pantoea ananatis.. Microbiologyopen 2(3):471-81 PMID: 23554367
- 8. Song J et al.. 2025. Metabolic Engineering of Escherichia coli for Self-Induced Production of l-Isoleucine.. ACS Synth Biol 14(1):179-192 PMID: 39681531
